Jeannie Capone: Discovering MTHFR 677TT in Clinical Practice
Jeannie Capone, Author and Independent Science Writer at The Neurolipid Notebook, shared a post on LinkedIn:
“It started as a way to get better at my job as a psychiatric nurse practitioner.
In 2022, I began using pharmacogenetic testing with my patients — not because it was trendy, but because I wanted to understand why some patients complained of side effects on multiple medications, and others didn’t.
We were taught the basics of medication metabolism in school but it was pretty light-weight information.
The report gave me information about my lovely liver (CYP enzymes), my UGTs (metabolizing drugs outside the liver) as well as pharmacodynamic genes like HTR2A and SLC6A4.
But there was a second page with just one test.
That’s when things stopped being abstract.
I found out I carry MTHFR 677TT.
This variant produces an enzyme with approximately 50% reduced activity compared to the normal form.
The enzyme’s job is to convert folate into 5-methyltetrahydrofolate — the form the body actually uses for DNA synthesis, methylation reactions, and homocysteine metabolism.
With two T copies, that conversion is impaired.
The result:
lower circulating folate, higher homocysteine, and a system that depends more heavily on adequate B-vitamin intake to function normally.
I brought it to my doctors expecting context — maybe a plan, maybe even reassurance.
After all, I had read that it is correlated with elevated risk of hypertension, hyperhomocysteinemia, cancer, depression, bipolar and heart disease….”
Stay updated with Hemostasis Today.
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA
-
May 5, 2026, 15:28Soumen Bhattacharyya: Hyperhomocysteinemia and Thrombosis – What Clinicians Should Know
-
May 5, 2026, 15:06Wolfgang Miesbach: How Should We Approach GI Angiodysplasia in VWD?
-
May 5, 2026, 14:48What Constitutes High Risk for Venous Thromboembolism? – JTH
-
May 5, 2026, 14:41How Real-Time Data, Rehabilitation Registries, and Patient-Reported Outcomes Can Transform Practice – European Stroke Organisation
-
May 5, 2026, 14:41Driving National Change for Bleeding Disorders – WFH